Clinical Research Directory
Browse clinical research sites, groups, and studies.
LET Optimized IMPT in Treating Pediatric Patients With Ependymoma
Sponsor: M.D. Anderson Cancer Center
Summary
This phase I trial studies the side effects of linear energy transfer (LET) optimized image modulated proton therapy (IMPT) in treating pediatric patients with ependymoma. Radiation therapy such as LET optimized IMPT, uses proton beams to kill tumor cells and shrink tumors without damaging surrounding normal tissues.
Official title: Pilot Trial of LET Optimized IMPT for Pediatric Patients With Ependymoma
Key Details
Gender
All
Age Range
Any - 22 Years
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2019-04-01
Completion Date
2027-12-31
Last Updated
2025-11-13
Healthy Volunteers
No
Conditions
Interventions
Linear Energy Transfer-Optimized Intensity Modulated Proton Therapy
Given LET optimized IMPT
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Ancillary studies
Locations (2)
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
M D Anderson Cancer Center
Houston, Texas, United States